PARP inhibition causes replication stress in preclinical models of high risk neuroblastoma and synergises with inhibition of ATR

被引:0
|
作者
Southgate, Harriet [1 ]
Curtin, Nicola J. [1 ]
Tweddle, Deborah A. [1 ]
机构
[1] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
57
引用
收藏
页码:20 / 20
页数:1
相关论文
共 50 条
  • [1] Preclinical investigation of ATR inhibition alone and in combination with PARP inhibition in high risk neuroblastoma
    Southgate, Harriet E.
    Chen, Lindi
    Curtin, Nicola J.
    Tweddle, Deborah A.
    CANCER RESEARCH, 2020, 80 (16)
  • [2] ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms
    Southgate, Harriet E. D.
    Chen, Lindi
    Tweddle, Deborah A.
    Curtin, Nicola J.
    CANCERS, 2020, 12 (05)
  • [3] PRMT blockade induces defective DNA replication stress response via ATR suppression and synergizes with PARP inhibition
    Bisht, Deepa
    Li, Yang
    Dobrolecki, Lacey E.
    Sallas, Christina
    Zhang, Xudong
    Kerr, Travis D.
    Wang, Yalong
    Awasthi, Sharad
    Kaundal, Babita
    Wu, Siqi
    Peng, Weiyi
    Mendillo, Marc L.
    Lu, Yiling
    Jeter, Collene R.
    Peng, Guang
    Liu, Jinsong
    Westin, Shannon N.
    Sood, Anil K.
    Lewis, Michael T.
    Das, Jishnu
    Yi, S. Stephen
    Bedford, Mark T.
    McGrail, Daniel J.
    Sahni, Nidhi
    CANCER RESEARCH, 2024, 84 (06)
  • [4] FLASH radiotherapy and PARP inhibition on preclinical models of glioblastoma and neurotoxicity
    Ruan, J.
    Tullis, I.
    Maguire, M.
    Dickie, B.
    Forster, D.
    Williams, K.
    Chalmers, A.
    Petersson, K.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S688 - S689
  • [5] PARP inhibition in UV-associated angiosarcoma preclinical models
    Weidema, Marije E.
    Desar, Ingrid M. E.
    Hillebrandt-Roeffen, Melissa H. S.
    van Erp, Anke E. M.
    Masuzawa, Mikio
    Meyer, J. W. R.
    Meyer, J. W. R.
    Hogenes, M. C. H.
    Flucke, Uta E.
    van der Graaf, Winette T. A.
    Versleijen-Jonkers, Yvonne M. H.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2579 - 2590
  • [6] PARP inhibition in UV-associated angiosarcoma preclinical models
    Marije E. Weidema
    Ingrid M. E. Desar
    Melissa H. S. Hillebrandt-Roeffen
    Anke E. M. van Erp
    Mikio Masuzawa
    Uta E. Flucke
    Winette T. A. van der Graaf
    Yvonne M. H. Versleijen-Jonkers
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2579 - 2590
  • [7] TARGETING REPLICATIVE STRESS IN BRAIN TUMORS BY COMBINING ATR AND PARP INHIBITION
    Sarvode, Supriya
    Refaat, Alaa
    DeVries, Rebekah
    Pal, Anasuya
    Tinkle, Christopher
    Shelat, Anang
    NEURO-ONCOLOGY, 2023, 25
  • [8] PARP inhibition-associated heterochromatin confers increased DNA replication stress and vulnerability to ATR inhibition in SMARCA4-deficient cells
    Yano, Kimiyoshi
    Kato, Megumi
    Endo, Syoju
    Igarashi, Taichi
    Wada, Ryoga
    Kohno, Takashi
    Zimmermann, Astrid
    Dahmen, Heike
    Zenke, Frank T.
    Shiotani, Bunsyo
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [9] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Kim, Hyoung
    Xu, Haineng
    George, Erin
    Hallberg, Dorothy
    Kumar, Sushil
    Jagannathan, Veena
    Medvedev, Sergey
    Kinose, Yasuto
    Devins, Kyle
    Verma, Priyanka
    Ly, Kevin
    Wang, Yifan
    Greenberg, Roger A.
    Schwartz, Lauren
    Johnson, Neil
    Scharpf, Robert B.
    Mills, Gordon B.
    Zhang, Rugang
    Velculescu, Victor E.
    Brown, Eric J.
    Simpkins, Fiona
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [10] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Hyoung Kim
    Haineng Xu
    Erin George
    Dorothy Hallberg
    Sushil Kumar
    Veena Jagannathan
    Sergey Medvedev
    Yasuto Kinose
    Kyle Devins
    Priyanka Verma
    Kevin Ly
    Yifan Wang
    Roger A. Greenberg
    Lauren Schwartz
    Neil Johnson
    Robert B. Scharpf
    Gordon B. Mills
    Rugang Zhang
    Victor E. Velculescu
    Eric J. Brown
    Fiona Simpkins
    Nature Communications, 11